Skip to main content
RPAY
NASDAQ Trade & Services

Parthenon Capital Affiliate Strikes Cooperation Deal with Repay, Adds Director to Board

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Neutral
Importance info
7
Price
$4.09
Mkt Cap
$360.276M
52W Low
$2.3
52W High
$6.055
52W Position info
78% above low
Off High info
32% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

RPAY sits 78% above its 52-week low of $2.3 on light trading volume (0.3× avg).

Summary

Parthenon Capital affiliate BT Parent GP struck a cooperation agreement with Repay Holdings, expanding the board and appointing Zach F. Sadek as a director. The move adds a shareholder-aligned voice to the board amid ongoing activist battles.


Key Events · Executive and Board Changes · RPAY

  • Cooperation Agreement with Parthenon Affiliate

    On July 13, 2026, BT Parent GP and Beckham Aggregator, which together hold 9.38% of Repay, entered a cooperation agreement with the company.

  • Board Expansion and Director Appointment

    The board was expanded from six to seven members, and Zach F. Sadek, a Parthenon partner, was appointed to fill the new seat, with a term expiring at the 2027 annual meeting.

  • Standstill Provisions

    The agreement includes customary standstill restrictions and confidentiality obligations, effective until 30 days after Sadek's departure or the conclusion of the 2027 annual meeting.

  • Activist Proxy Battle Context

    The cooperation agreement arrives as activists Forager Fund and Veradace Capital have been pushing for board changes and a sale of the company, with Forager recently raising its buyout offer to $5.25 per share.


Analysis · RPAY · Trade & Services

On July 13, 2026, BT Parent GP and Beckham Aggregator—affiliates of Parthenon Capital—entered a cooperation agreement with Repay Holdings. The board was expanded from six to seven members, and Zach F. Sadek, a Parthenon partner, was appointed to fill the new seat. This move comes amid a heated proxy battle with activists Forager Fund and Veradace Capital, who have been pushing for board changes and a sale. By adding a director aligned with a major shareholder, Repay may be seeking to shore up support ahead of its annual meeting, potentially blunting activist pressure. The agreement includes standstill provisions, limiting further activism from Parthenon through at least the 2027 annual meeting.

At the time of this filing, RPAY was trading at $4.09 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $360.3M. The 52-week trading range was $2.30 to $6.06. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RPAY - Latest Insights

RPAY
Jul 15, 2026, 5:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
RPAY
Jul 14, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
RPAY
Jul 13, 2026, 5:31 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
RPAY
Jun 29, 2026, 1:28 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
RPAY
Jun 29, 2026, 8:39 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
RPAY
Jun 15, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
8
RPAY
Jun 12, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
RPAY
Jun 04, 2026, 3:53 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
RPAY
Jun 03, 2026, 3:59 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
RPAY
Jun 01, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
9